RUNX1 anticorps (AA 6-10)
Aperçu rapide pour RUNX1 anticorps (AA 6-10) (ABIN871678)
Antigène
Voir toutes RUNX1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 6-10
-
Specificité
- The antibody detects endogenous level of total AML1 (RUNX1) protein.
-
Purification
- Affinity purified
-
Immunogène
- Peptide sequence around AA 6-10 (D-A-S-T-S) derived from Human AML1 (RUNX1) . Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
-
-
-
-
Indications d'application
- Western blotting: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))
-
Autre désignation
- AML1 (RUNX1)
-
Sujet
- CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The a subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits MYST4-dependent transcriptional activation.
-
Poids moléculaire
- 55 kDa
-
ID gène
- 861
-
NCBI Accession
- NP_001116
-
UniProt
- Q01196
Antigène
-